Taken together, these results suggest that GSE-based protection against carcinogenesis could be mediated by its anti-inflammatory activity through down regulating NF-κB, COX-2 and iNOS expressions levels and decreasing leukocytes infiltrations as well as the expressions of both TNFα and its receptors in tumor cells. The gene discussed is PTGS2; the disease is neoplasm.